<html>
<head>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8">
</head>
<body dir="auto">
Hi Marika,
<div><br>
</div>
<div>Having confirmation from neither of them that they’re willing or able, I would like to nominate Jan and Laureen for two of the presentation slots. <br>
<br>
<div dir="ltr">
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; vertical-align: baseline;">
<span style="background-color: rgba(255, 255, 255, 0);"><a name="_MailAutoSig"><b><span style="position: relative; top: -0.5pt;">Brian J. King</span></b></a><br>
<span style="position: relative; top: -0.5pt;">Head of Policy and Advocacy, Intellectual Property Group</span><o:p></o:p></span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; vertical-align: baseline;">
<span style="background-color: rgba(255, 255, 255, 0);"><br>
<span style="position: relative; top: -0.5pt;">T +1 443 761 3726</span><o:p></o:p></span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; vertical-align: baseline;">
<span style="background-color: rgba(255, 255, 255, 0);"><u><span style="position: relative; top: -0.5pt;">clarivate.com</span></u></span></p>
</div>
<div dir="ltr"><br>
<blockquote type="cite">On Jun 7, 2021, at 11:06 AM, Marika Konings via Gnso-epdp-team <gnso-epdp-team@icann.org> wrote:<br>
<br>
</blockquote>
</div>
<blockquote type="cite">
<div dir="ltr">
<meta name="Generator" content="Microsoft Word 15 (filtered medium)">
<style><!--
/* Font Definitions */
@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0cm;
font-size:11.0pt;
font-family:"Calibri",sans-serif;
mso-fareast-language:EN-US;}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
{mso-style-priority:34;
mso-margin-top-alt:auto;
margin-right:0cm;
mso-margin-bottom-alt:auto;
margin-left:0cm;
font-size:12.0pt;
font-family:"Times New Roman",serif;
mso-fareast-language:EN-US;}
span.EmailStyle17
{mso-style-type:personal-compose;
font-family:"Calibri",sans-serif;
color:windowtext;}
.MsoChpDefault
{mso-style-type:export-only;
font-family:"Calibri",sans-serif;
mso-fareast-language:EN-US;}
@page WordSection1
{size:612.0pt 792.0pt;
margin:72.0pt 72.0pt 72.0pt 72.0pt;}
div.WordSection1
{page:WordSection1;}
/* List Definitions */
@list l0
{mso-list-id:770199161;
mso-list-type:hybrid;
mso-list-template-ids:1621901280 2139232284 67698713 67698689 67698703 67698713 67698715 67698703 67698713 67698715;}
@list l0:level1
{mso-level-tab-stop:none;
mso-level-number-position:left;
margin-left:68.1pt;
text-indent:-50.0pt;
mso-ansi-font-size:11.0pt;
font-family:"Calibri",sans-serif;
color:black;
mso-ansi-font-weight:normal;
mso-bidi-font-weight:normal;}
@list l0:level2
{mso-level-number-format:alpha-lower;
mso-level-tab-stop:none;
mso-level-number-position:left;
margin-left:72.1pt;
text-indent:-18.0pt;}
@list l0:level3
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:none;
mso-level-number-position:left;
margin-left:117.1pt;
text-indent:-18.0pt;
font-family:Symbol;}
@list l0:level4
{mso-level-tab-stop:none;
mso-level-number-position:left;
margin-left:144.1pt;
text-indent:-18.0pt;}
@list l0:level5
{mso-level-number-format:alpha-lower;
mso-level-tab-stop:none;
mso-level-number-position:left;
margin-left:180.1pt;
text-indent:-18.0pt;}
@list l0:level6
{mso-level-number-format:roman-lower;
mso-level-tab-stop:none;
mso-level-number-position:right;
margin-left:216.1pt;
text-indent:-9.0pt;}
@list l0:level7
{mso-level-tab-stop:none;
mso-level-number-position:left;
margin-left:252.1pt;
text-indent:-18.0pt;}
@list l0:level8
{mso-level-number-format:alpha-lower;
mso-level-tab-stop:none;
mso-level-number-position:left;
margin-left:288.1pt;
text-indent:-18.0pt;}
@list l0:level9
{mso-level-number-format:roman-lower;
mso-level-tab-stop:none;
mso-level-number-position:right;
margin-left:324.1pt;
text-indent:-9.0pt;}
ol
{margin-bottom:0cm;}
ul
{margin-bottom:0cm;}
--></style>
<div class="WordSection1">
<p class="MsoNormal"><span lang="EN-US">Dear EPDP Team,<o:p></o:p></span></p>
<p class="MsoNormal"><span lang="EN-US"><o:p> </o:p></span></p>
<p class="MsoNormal"><span lang="EN-US">Please find below the proposed agenda for the next EPDP Team meeting which is scheduled for Thursday 10 June at 14.00 UTC.
<o:p></o:p></span></p>
<p class="MsoNormal"><span lang="EN-US"><o:p> </o:p></span></p>
<p class="MsoNormal"><span lang="EN-US">Also attached you will find the ICANN71 session proposal. Please review this in advance of the meeting and feel free to provide any feedback you may have and/or indicate if you are willing to volunteer for any of the
identified speaker slots.<o:p></o:p></span></p>
<p class="MsoNormal"><span lang="EN-US"><o:p> </o:p></span></p>
<p class="MsoNormal"><span lang="EN-US">Best regards,<o:p></o:p></span></p>
<p class="MsoNormal"><span lang="EN-US"><o:p> </o:p></span></p>
<p class="MsoNormal"><span lang="EN-US">Caitlin, Berry and Marika<o:p></o:p></span></p>
<div style="mso-element:para-border-div;border:none;border-bottom:double windowtext 2.25pt;padding:0cm 0cm 1.0pt 0cm">
<p class="MsoNormal" style="border:none;padding:0cm"><span lang="EN-US"><o:p> </o:p></span></p>
</div>
<p class="MsoNormal"><span lang="EN-US"><o:p> </o:p></span></p>
<p class="MsoNormal"><b><span style="color:black">EPDP Phase 2A - Meeting #29</span></b><span style="color:black"><o:p></o:p></span></p>
<p class="MsoNormal"><b><span style="color:black">Proposed Agenda</span></b><span style="color:black"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="color:black">Tuesday 10 June 2021 at 14.00 UTC<o:p></o:p></span></p>
<p class="MsoNormal"><span style="color:black"> <o:p></o:p></span></p>
<p class="MsoListParagraph" style="mso-margin-top-alt:0cm;margin-right:0cm;margin-bottom:0cm;margin-left:2.0cm;text-indent:-38.7pt;mso-list:l0 level1 lfo1">
<!--[if !supportLists]--><span lang="EN-US" style="font-size:11.0pt;font-family:"Calibri",sans-serif;color:black"><span style="mso-list:Ignore">1.<span style="font:7.0pt "Times New Roman"">
</span></span></span><!--[endif]--><span lang="EN-US" style="font-size:11.0pt;font-family:"Calibri",sans-serif;color:black">Roll Call & SOI Updates (5 minutes)<o:p></o:p></span></p>
<p class="MsoListParagraph" style="mso-margin-top-alt:0cm;margin-right:0cm;margin-bottom:0cm;margin-left:67.7pt">
<span lang="EN-US" style="font-size:11.0pt;font-family:"Calibri",sans-serif;color:black"><o:p> </o:p></span></p>
<p class="MsoListParagraph" style="mso-margin-top-alt:0cm;margin-right:0cm;margin-bottom:0cm;margin-left:2.0cm;text-indent:-38.7pt;mso-list:l0 level1 lfo1">
<!--[if !supportLists]--><span lang="EN-US" style="font-size:11.0pt;font-family:"Calibri",sans-serif;color:black"><span style="mso-list:Ignore">2.<span style="font:7.0pt "Times New Roman"">
</span></span></span><!--[endif]--><span lang="EN-US" style="font-size:11.0pt;font-family:"Calibri",sans-serif;color:black">Welcome & Chair updates (Chair) (5 minutes)<o:p></o:p></span></p>
<p class="MsoListParagraph" style="mso-margin-top-alt:0cm;margin-right:0cm;margin-bottom:0cm;margin-left:72.1pt;text-indent:-15.4pt;mso-list:l0 level2 lfo1">
<!--[if !supportLists]--><span lang="EN-US" style="font-size:11.0pt;font-family:"Calibri",sans-serif;color:black"><span style="mso-list:Ignore">a.<span style="font:7.0pt "Times New Roman"">
</span></span></span><!--[endif]--><span lang="EN-US" style="font-size:11.0pt;font-family:"Calibri",sans-serif;color:black">Publication of Initial Report & Chair’s statement<o:p></o:p></span></p>
<p class="MsoListParagraph" style="mso-margin-top-alt:0cm;margin-right:0cm;margin-bottom:0cm;margin-left:2.0cm">
<span lang="EN-US" style="font-size:11.0pt;font-family:"Calibri",sans-serif;color:black"><o:p> </o:p></span></p>
<p class="MsoListParagraph" style="mso-margin-top-alt:0cm;margin-right:0cm;margin-bottom:0cm;margin-left:2.0cm;text-indent:-38.7pt;mso-list:l0 level1 lfo1">
<!--[if !supportLists]--><span lang="EN-US" style="font-size:11.0pt;font-family:"Calibri",sans-serif;color:black"><span style="mso-list:Ignore">3.<span style="font:7.0pt "Times New Roman"">
</span></span></span><!--[endif]--><span lang="EN-US" style="font-size:11.0pt;font-family:"Calibri",sans-serif;color:black">ICANN71 Session Proposal (30 minutes)<o:p></o:p></span></p>
<p class="MsoListParagraph" style="mso-margin-top-alt:0cm;margin-right:0cm;margin-bottom:0cm;margin-left:72.1pt;text-indent:-15.4pt;mso-list:l0 level2 lfo1">
<!--[if !supportLists]--><span lang="EN-US" style="font-size:11.0pt;font-family:"Calibri",sans-serif;color:black"><span style="mso-list:Ignore">a.<span style="font:7.0pt "Times New Roman"">
</span></span></span><!--[endif]--><span lang="EN-US" style="font-size:11.0pt;font-family:"Calibri",sans-serif;color:black">Brief overview of proposed session (see attached)<o:p></o:p></span></p>
<p class="MsoListParagraph" style="mso-margin-top-alt:0cm;margin-right:0cm;margin-bottom:0cm;margin-left:72.1pt;text-indent:-15.4pt;mso-list:l0 level2 lfo1">
<!--[if !supportLists]--><span lang="EN-US" style="font-size:11.0pt;font-family:"Calibri",sans-serif;color:black"><span style="mso-list:Ignore">b.<span style="font:7.0pt "Times New Roman"">
</span></span></span><!--[endif]--><span lang="EN-US" style="font-size:11.0pt;font-family:"Calibri",sans-serif;color:black">EPDP Team feedback & identification of volunteers<o:p></o:p></span></p>
<p class="MsoListParagraph" style="mso-margin-top-alt:0cm;margin-right:0cm;margin-bottom:0cm;margin-left:72.1pt;text-indent:-15.4pt;mso-list:l0 level2 lfo1">
<!--[if !supportLists]--><span lang="EN-US" style="font-size:11.0pt;font-family:"Calibri",sans-serif;color:black"><span style="mso-list:Ignore">c.<span style="font:7.0pt "Times New Roman"">
</span></span></span><!--[endif]--><span lang="EN-US" style="font-size:11.0pt;font-family:"Calibri",sans-serif;color:black">Confirm next steps<o:p></o:p></span></p>
<p class="MsoListParagraph" style="mso-margin-top-alt:0cm;margin-right:0cm;margin-bottom:0cm;margin-left:2.0cm">
<span lang="EN-US" style="font-size:11.0pt;font-family:"Calibri",sans-serif;color:black"><o:p> </o:p></span></p>
<p class="MsoListParagraph" style="mso-margin-top-alt:0cm;margin-right:0cm;margin-bottom:0cm;margin-left:2.0cm;text-indent:-38.7pt;mso-list:l0 level1 lfo1">
<!--[if !supportLists]--><span lang="EN-US" style="font-size:11.0pt;font-family:"Calibri",sans-serif;color:black"><span style="mso-list:Ignore">4.<span style="font:7.0pt "Times New Roman"">
</span></span></span><!--[endif]--><span lang="EN-US" style="font-size:11.0pt;font-family:"Calibri",sans-serif;color:black">Intermediary work through the Public Comment (30 minutes)<o:p></o:p></span></p>
<p class="MsoListParagraph" style="mso-margin-top-alt:0cm;margin-right:0cm;margin-bottom:0cm;margin-left:72.1pt;text-indent:-15.4pt;mso-list:l0 level2 lfo1">
<!--[if !supportLists]--><span lang="EN-US" style="font-size:11.0pt;font-family:"Calibri",sans-serif;color:black"><span style="mso-list:Ignore">a.<span style="font:7.0pt "Times New Roman"">
</span></span></span><!--[endif]--><span lang="EN-US" style="font-size:11.0pt;font-family:"Calibri",sans-serif;color:black">General discussion of what can be accomplished working off-line until the public comment closes 19 July 2021<o:p></o:p></span></p>
<p class="MsoListParagraph" style="mso-margin-top-alt:0cm;margin-right:0cm;margin-bottom:0cm;margin-left:72.1pt;text-indent:-15.4pt;mso-list:l0 level2 lfo1">
<!--[if !supportLists]--><span lang="EN-US" style="font-size:11.0pt;font-family:"Calibri",sans-serif;color:black"><span style="mso-list:Ignore">b.<span style="font:7.0pt "Times New Roman"">
</span></span></span><!--[endif]--><span lang="EN-US" style="font-size:11.0pt;font-family:"Calibri",sans-serif;color:black">Consider possible mediated discussions<o:p></o:p></span></p>
<p class="MsoListParagraph" style="mso-margin-top-alt:0cm;margin-right:0cm;margin-bottom:0cm;margin-left:72.1pt;text-indent:-15.4pt;mso-list:l0 level2 lfo1">
<!--[if !supportLists]--><span lang="EN-US" style="font-size:11.0pt;font-family:"Calibri",sans-serif;color:black"><span style="mso-list:Ignore">c.<span style="font:7.0pt "Times New Roman"">
</span></span></span><!--[endif]--><span lang="EN-US" style="font-size:11.0pt;font-family:"Calibri",sans-serif;color:black">Confirm next steps<o:p></o:p></span></p>
<p class="MsoNormal" style="vertical-align:baseline"><span style="color:black"><o:p> </o:p></span></p>
<p class="MsoListParagraph" style="mso-margin-top-alt:0cm;margin-right:0cm;margin-bottom:0cm;margin-left:35.45pt;text-indent:-17.45pt;mso-list:l0 level1 lfo1">
<!--[if !supportLists]--><span lang="EN-US" style="font-size:11.0pt;font-family:"Calibri",sans-serif;color:black"><span style="mso-list:Ignore">5.<span style="font:7.0pt "Times New Roman"">
</span></span></span><!--[endif]--><span lang="EN-US" style="font-size:11.0pt;font-family:"Calibri",sans-serif;color:black">Wrap and confirm next EPDP Team meeting (5 minutes):<o:p></o:p></span></p>
<p class="MsoListParagraph" style="mso-margin-top-alt:0cm;margin-right:0cm;margin-bottom:0cm;margin-left:72.1pt;text-indent:-15.4pt;mso-list:l0 level2 lfo1">
<!--[if !supportLists]--><span lang="EN-US" style="font-size:11.0pt;font-family:"Calibri",sans-serif;color:black"><span style="mso-list:Ignore">a.<span style="font:7.0pt "Times New Roman"">
</span></span></span><!--[endif]--><span lang="EN-US" style="font-size:11.0pt;font-family:"Calibri",sans-serif;color:black">EPDP Team Meeting #30 Thursday 15 July at 14.00 UTC (tentative)<o:p></o:p></span></p>
<p class="MsoListParagraph" style="mso-margin-top-alt:0cm;margin-right:0cm;margin-bottom:0cm;margin-left:72.1pt;text-indent:-15.4pt;mso-list:l0 level2 lfo1">
<!--[if !supportLists]--><span lang="EN-US" style="font-size:11.0pt;font-family:"Calibri",sans-serif;color:black"><span style="mso-list:Ignore">b.<span style="font:7.0pt "Times New Roman"">
</span></span></span><!--[endif]--><span lang="EN-US" style="font-size:11.0pt;font-family:"Calibri",sans-serif;color:black">Meeting #31 Thursday 22 July (confirmed)<o:p></o:p></span></p>
<p class="MsoListParagraph" style="mso-margin-top-alt:0cm;margin-right:0cm;margin-bottom:0cm;margin-left:72.1pt;text-indent:-15.4pt;mso-list:l0 level2 lfo1">
<!--[if !supportLists]--><span lang="EN-US" style="font-size:11.0pt;font-family:"Calibri",sans-serif;color:black"><span style="mso-list:Ignore">c.<span style="font:7.0pt "Times New Roman"">
</span></span></span><!--[endif]--><span lang="EN-US" style="font-size:11.0pt;font-family:"Calibri",sans-serif;color:black">Confirm action items<o:p></o:p></span></p>
<p class="MsoListParagraph" style="mso-margin-top-alt:0cm;margin-right:0cm;margin-bottom:0cm;margin-left:72.1pt;text-indent:-15.4pt;mso-list:l0 level2 lfo1">
<!--[if !supportLists]--><span lang="EN-US" style="font-size:11.0pt;font-family:"Calibri",sans-serif"><span style="mso-list:Ignore">d.<span style="font:7.0pt "Times New Roman"">
</span></span></span><!--[endif]--><span lang="EN-US" style="font-size:11.0pt;font-family:"Calibri",sans-serif;color:black">Confirm questions for ICANN Org, if any</span><span lang="EN-US" style="font-size:11.0pt;font-family:"Calibri",sans-serif"><o:p></o:p></span></p>
<p class="MsoNormal"><span lang="EN-US"><o:p> </o:p></span></p>
</div>
<div><ICANN71. EPDP Phase 2A Session - 3 June 2021.docx></div>
<span>_______________________________________________</span><br>
<span>Gnso-epdp-team mailing list</span><br>
<span>Gnso-epdp-team@icann.org</span><br>
<span>https://urldefense.proofpoint.com/v2/url?u=https-3A__mm.icann.org_mailman_listinfo_gnso-2Depdp-2Dteam&d=DwICAg&c=OGmtg_3SI10Cogwk-ShFiw&r=qQNCXqU_XE2XIdXbawYmk-YDflYH6pd8ffXlzxU37OA&m=imRJttJ--N_lac1re612EcEkvQogwamFqxF3hYib-sQ&s=3Ehu2eH37QRKug3ncGoBao1sifYd0pBjlDLfikPkrOA&e=
</span><br>
<span>_______________________________________________</span><br>
<span>By submitting your personal data, you consent to the processing of your personal data for purposes of subscribing to this mailing list accordance with the ICANN Privacy Policy (https://urldefense.proofpoint.com/v2/url?u=https-3A__www.icann.org_privacy_policy&d=DwICAg&c=OGmtg_3SI10Cogwk-ShFiw&r=qQNCXqU_XE2XIdXbawYmk-YDflYH6pd8ffXlzxU37OA&m=imRJttJ--N_lac1re612EcEkvQogwamFqxF3hYib-sQ&s=y5o2svvexCj1FG773qdpWV_seJOgMzsLlDFMCHt1els&e=
) and the website Terms of Service (https://urldefense.proofpoint.com/v2/url?u=https-3A__www.icann.org_privacy_tos&d=DwICAg&c=OGmtg_3SI10Cogwk-ShFiw&r=qQNCXqU_XE2XIdXbawYmk-YDflYH6pd8ffXlzxU37OA&m=imRJttJ--N_lac1re612EcEkvQogwamFqxF3hYib-sQ&s=cSqQ6atMGeafvoIiOBUbsqNwDwhShqdxwjrXR7d00BE&e=
). You can visit the Mailman link above to change your membership status or configuration, including unsubscribing, setting digest-style delivery or disabling delivery altogether (e.g., for a vacation), and so on.</span></div>
</blockquote>
</div>
<div>
<p style="font-size:8pt; line-height:8pt; font-family: 'Calibri',serif; color:#696969">
Confidentiality note: This e-mail may contain confidential information from Clarivate. If you are not the intended recipient, be aware that any disclosure, copying, distribution or use of the contents of this e-mail is strictly prohibited. If you have received
this e-mail in error, please delete this e-mail and notify the sender immediately.
</p>
</div>
</body>
</html>